BIOD351 / BIOD 351 Module 9 (Latest Update 2025 / 2026) Pharmacology | Questions & Answers | Grade A | 100% Correct - Portage Learning

BIOD351 / BIOD 351 Module 9
(Latest Update )
Pharmacology | Questions &
Answers | Grade A | 100% Correct -
Portage Learning

Question:
________ are classified as lymphokines.


A. Interferons
B. Monoclonal antibodies
C. Rebif
D. Interleukins
Answer:
Interleukins




Question:
True or False: Ledipasvir/sofosbuvir (Harvoni) is a direct-acting antiviral
medication used to treat hepatitis C.
Answer:
True

,Question:
Bevacizumab (Avastin) works by:


A. Binding to and inhibiting vascular endothelial growth factor
B. Inhibiting the binding of IL-1 to its many receptor sites
C. Preventing TNF molecules from binding to the TNF cell surface
D. Binding to the alpha4 subunit of integrins
Answer:
a.) Binding to and inhibiting vascular endothelial growth factor




Question:
Which of the following medications works by inhibiting T-cell activation?


A. Adalimumab
B. Aldesleukin (IL-2)
C. Abatacept
D. Etanercept
Answer:
Abatacept

, Question:
Which of the following drugs is part of a direct-acting antiviral treatment for
hepatitis C?


A) Zidovudine (Retrovir)
B) Ledipasvir/sofosbuvir (Harvoni)
C) Enfuvirtide (Fuzeon)
D) Darunavir (Prezista)
Answer:
B) Ledipasvir/sofosbuvir (Harvoni)




Question:
What is the primary mechanism of action for NRTIs in the treatment of HIV?


A) Inhibiting protease enzyme
B) Preventing fusion of the virus to the host cell
C) Blocking reverse transcriptase by incorporating into viral DNA
D) Inhibiting integrase enzyme
Answer:
C) Blocking reverse transcriptase by incorporating into viral DNA